Smart Brain co-finances the research and development of the medicinal substance MitoTam being carried out by the Czech Academy of Sciences
Results obtained so far show that MitoTam is highly effective in fighting breast cancer, including the most aggressive type, HER2+
Clinical trials of MitoTam are currently under way. KKCG estimates that investments in the first two rounds of testing will amount to six million dollars
We hold a majority ownership interest in Smart Brain